X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (25) 25
melanoma (21) 21
humans (15) 15
oncology (11) 11
prognosis (10) 10
research (10) 10
female (8) 8
male (8) 8
care and treatment (7) 7
immunotherapy (7) 7
ipilimumab (7) 7
metastasis (7) 7
middle aged (7) 7
aged (6) 6
cancer (6) 6
melanoma - drug therapy (6) 6
melanoma - genetics (6) 6
dermatology (5) 5
hematology (5) 5
hematology, oncology and palliative medicine (5) 5
medical research (5) 5
overall survival (5) 5
skin neoplasms - pathology (5) 5
survival (5) 5
adult (4) 4
aged, 80 and over (4) 4
best overall response (4) 4
biochemical research methods (4) 4
biotechnology & applied microbiology (4) 4
ctla-4 variants (4) 4
expressed sequence tags (4) 4
immunology (4) 4
malignant-melanoma (4) 4
mathematical & computational biology (4) 4
medicine, experimental (4) 4
melanoma - metabolism (4) 4
melanoma - pathology (4) 4
metastatic melanoma (4) 4
mutation (4) 4
predictive (4) 4
predictive/prognostic factor (4) 4
proteins (4) 4
resistance (4) 4
risk factors (4) 4
treatment outcome (4) 4
tumors (4) 4
user-computer interface (4) 4
algorithms (3) 3
analysis (3) 3
animals (3) 3
biochemistry (3) 3
braf (3) 3
braf inhibitors (3) 3
combined nivolumab (3) 3
computer science applications (3) 3
cutaneous melanoma (3) 3
cytotoxicity (3) 3
dabrafenib (3) 3
database (3) 3
database management systems (3) 3
databases, genetic (3) 3
disease-free survival (3) 3
double-blind (3) 3
drug therapy (3) 3
italy (3) 3
medical prognosis (3) 3
melanoma - mortality (3) 3
molecular biology (3) 3
open-label (3) 3
patient outcomes (3) 3
pd-1 (3) 3
pd-l1 (3) 3
retrospective studies (3) 3
skin neoplasms - drug therapy (3) 3
skin neoplasms - genetics (3) 3
software (3) 3
tool (3) 3
usage (3) 3
vemurafenib (3) 3
abridged index medicus (2) 2
activation (2) 2
adolescent (2) 2
antineoplastic agents - therapeutic use (2) 2
apoptosis (2) 2
astronomy & astrophysics (2) 2
beta-catenin (2) 2
biology (2) 2
blood coagulation (2) 2
cancer therapies (2) 2
clinical trials (2) 2
computer applications to medicine. medical informatics (2) 2
confidence intervals (2) 2
databases, nucleic acid (2) 2
diagnosis (2) 2
dosage and administration (2) 2
early detection of cancer - methods (2) 2
genetic aspects (2) 2
genome (2) 2
health aspects (2) 2
immune checkpoint inhibitors (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 10/2017, Volume 18, Issue 5, pp. 597 - 611
The use of monoclonal antibodies that block immunologic checkpoints, which mediate adaptive immune resistance, has revolutionized the treatment of metastatic... 
SURVIVAL | POOR-PROGNOSIS | COMBINED NIVOLUMAB | DOUBLE-BLIND | RESISTANCE | OPEN-LABEL | BRAF | MYELOID CELLS | PD-1 | PLUS IPILIMUMAB | DERMATOLOGY | Index Medicus
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 05/2018, Volume 95, pp. 130 - 132
Journal Article
JOURNAL FOR IMMUNOTHERAPY OF CANCER, ISSN 2051-1426, 11/2019, Volume 7, Issue 1, pp. 1 - 13
Background Clinical response to MAPK inhibitors in metastatic melanoma patients is heterogeneous for reasons still needing to be elucidated. As the patient... 
T lymphocytes | DABRAFENIB | Myeloid cells | MULTICENTER | OPEN-LABEL | BRAF | Microenvironment | IMMUNOLOGY | BETA-CATENIN | Melanoma prognosis | ONCOLOGY | IMMUNOTHERAPY | POOR-PROGNOSIS | MUTATED METASTATIC MELANOMA | DOUBLE-BLIND | VEMURAFENIB
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 1756-9966, 04/2014, Volume 33, Issue 1, p. 30
Journal Article
Journal Article
Journal of Clinical Pathology, ISSN 0021-9746, 02/2015, Volume 68, Issue 2, pp. 130 - 134
Journal Article
Skeletal radiology, ISSN 0364-2348, 01/2020
To assess the added value of serial 2-deoxy-2-[18F]fluoro-D-glucose (FDG) uptake analysis in predicting clinical response to treatment in infectious... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 461 - 461
Introduction Abnormalities of markers of blood clotting activation characterize the development of most cancers, including malignant melanoma, which still... 
Journal Article